2023 Europe Hematology and Flow Cytometry Analyzers and Reagents Market in France, Germany, Italy, Spain, UK-2022 Supplier Shares, 2022-2027 Test Volume and Sales Segment Forecasts for over 40 Individual Tests Performed in Hospitals, Commercial/Private Labs, POC Locations—Competitive Strategies, Instrumentation Pipeline, Emerging Technologies, Opportunities for Suppliers, Market Challenges
This unique report from LeadingMarketResearch.com provides information and analysisnot available from any other published source.
Summary
This comprehensive five-country report is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the European hematology and flow cytometry markets during the next five years.
The report is available by section, and can be customized to specific information needs and budget. The report explores business and technological trends in the major European countries (France, Germany, Italy, Spain, UK); provides market share estimates, test volume forecasts, and instrument placements; compares features of major analyzers; profiles leading competitors and emerging market entrants; and suggests specific product and marketing opportunities facing suppliers.
Rationale
During the next five years, continued advances in molecular diagnostics, monoclonal antibodies, lasers and IT, as well as growing understanding of immunologic forces regulating systemic diseases, will have a profound impact on the hematology and flow cytometry markets worldwide. New molecular diagnostic and monoclonal antibody tests will facilitate existing procedures and provide basis for sensitive, specific and simple assays. The introduction of smaller and easy-to-operate laser systems will further expand applications of flow cytometry to routine clinical laboratories. Further advances in IT will reduce the cost of instrument manufacture, service warranty, and permit development of self-troubleshooting, autocalibration and other advanced features. Presently tedious analyses of chromosomal abnormalities, DNA content, and lymphocyte subsets will become more automated and routine.
Hematology Tests
CBC + 5-Part Differential, Manual Differential/Review, Hematocrit (Automated, Manual), Hemoglobin (Automated, Manual), Sedimentation Rate, Reticulocytes, WBC (Automated, Manual), Platelets (Automated, Manual), Bone Marrow Analysis, RBC, Eosinophils.
Flow Cytometry Tests
Cell Surface Markers (CD4/CD8/T&B Lymphocytes, CD34, Others), Chemotherapy Monitoring (Leukemia/Lymphoma, Others), HLA Typing, Sperm Analysis, Cell Cycle Kinetics, Cell Function Testing, Chromosomal Abnormalities, Fetal Cell Analysis, Granulocyte Function, Receptor DNA/RNA Analysis, Cell Culturing.
Sales and Market Share Analysis
Sales and market shares of major instrument and reagent suppliers.
Geographic Coverage
France, Germany, Italy, Japan, Spain, UK
Competitive Assessments
Extensive strategic profiles of major suppliers and emerging market entrants.
Market Segmentation Analysis
Assessment of current and emerging technologies, and their potential market applications.
Comprehensive lists of companies developing or marketing new technologies and products by test.
Strategic Recommendations
Summary
This comprehensive five-country report is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the European hematology and flow cytometry markets during the next five years.
The report is available by section, and can be customized to specific information needs and budget. The report explores business and technological trends in the major European countries (France, Germany, Italy, Spain, UK); provides market share estimates, test volume forecasts, and instrument placements; compares features of major analyzers; profiles leading competitors and emerging market entrants; and suggests specific product and marketing opportunities facing suppliers.
Rationale
During the next five years, continued advances in molecular diagnostics, monoclonal antibodies, lasers and IT, as well as growing understanding of immunologic forces regulating systemic diseases, will have a profound impact on the hematology and flow cytometry markets worldwide. New molecular diagnostic and monoclonal antibody tests will facilitate existing procedures and provide basis for sensitive, specific and simple assays. The introduction of smaller and easy-to-operate laser systems will further expand applications of flow cytometry to routine clinical laboratories. Further advances in IT will reduce the cost of instrument manufacture, service warranty, and permit development of self-troubleshooting, autocalibration and other advanced features. Presently tedious analyses of chromosomal abnormalities, DNA content, and lymphocyte subsets will become more automated and routine.
Hematology Tests
CBC + 5-Part Differential, Manual Differential/Review, Hematocrit (Automated, Manual), Hemoglobin (Automated, Manual), Sedimentation Rate, Reticulocytes, WBC (Automated, Manual), Platelets (Automated, Manual), Bone Marrow Analysis, RBC, Eosinophils.
Flow Cytometry Tests
Cell Surface Markers (CD4/CD8/T&B Lymphocytes, CD34, Others), Chemotherapy Monitoring (Leukemia/Lymphoma, Others), HLA Typing, Sperm Analysis, Cell Cycle Kinetics, Cell Function Testing, Chromosomal Abnormalities, Fetal Cell Analysis, Granulocyte Function, Receptor DNA/RNA Analysis, Cell Culturing.
Sales and Market Share Analysis
Sales and market shares of major instrument and reagent suppliers.
Geographic Coverage
France, Germany, Italy, Japan, Spain, UK
Competitive Assessments
Extensive strategic profiles of major suppliers and emerging market entrants.
Market Segmentation Analysis
- Sales and market share estimates for leading suppliers of hematology and flow cytometry products by country.
- Test and sales forecasts for over 40 procedures by country, individual test and market segment:
- Hospitals
- Commercial/Private Laboratories
- Ambulatory Care Centers
- Physician Offices/Group Practices
- Analysis of current and emerging hematology and flow cytometry tests
- Reagent and instrument sales forecasts by market segment
- Instrument placements and installed base by manufacturer and model
- Sales and market shares of reagent and instrument suppliers
Assessment of current and emerging technologies, and their potential market applications.
Comprehensive lists of companies developing or marketing new technologies and products by test.
Strategic Recommendations
- New product development opportunities with significant market appeal.
- Alternative market penetration strategies.
- Potential market entry barriers and risks.
I. INTRODUCTION
II. WORLDWIDE MARKET OVERVIEW
III. MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES
A. Instrumentation
B. Reagent Kits and Test Systems/Panels
C. Information Technology
D. Auxiliary Products
IV. DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS
V. ALTERNATIVE MARKET PENETRATION STRATEGIES
VI. POTENTIAL MARKET ENTRY BARRIERS AND RISKS
VII. WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW
A. Major Routine and Special Hematology Tests
1. Introduction
2. CBC Analysis
a. Hemoglobin Concentration
b. Hematocrit Determination
c. Red Blood Cell Count
d. Red Cell Indices
MCV
RDW
MCHC
CHCM
HDW
MCH
e. Red Cell Size Histograms
f. Platelets
Platelet Count
Platelet Size/MPV
PDW
Automated Systems
g. Reticulocytes
3. White Blood Cell Analysis
a. WBC Count
b. Five-Partial Differential Major Suppliers
c. Pattern Recognition Systems
d. Comparison of Major Differential Analyzers
4. Reticulocytes
5. Platelet Function Tests
6. Erythrocyte Sedimentation Rate/CRP
7. Red Cell Analysis
8. 2, 3 DPG
9. Red Cell Deformability
10. Neutrophil Function Tests
11. Semen Analysis
12. Bone Marrow Analysis
13. Urinalysis
B. Major Flow Cytometry Applications
1. Cell Surface Markers
a. Lymphocyte Subclassification CD4/CD8/CD34
Instrumentation and Reagent Test Kits
b. Other Cell Markers
2. DNA Content Analysis
3. RNA Content Analysis
4. Chemotherapy Monitoring
5. Cell Cycle Analysis
6. Chromosome Analysis
7. Fetal Cell Analysis
8. HLA Typing
9. Microbiology
10. Protein Content Analysis
11. Multiparameter Analysis
12. Other Applications
C. Hematology and Flow Cytometry Instrumentation Review
1. Hematology Analyzers
a. Overview
Electrical Aperture-Impedance Analyzers
Light Scatter Analyzers
b. Review of major analyzers from:
Abbott, Beckman Coulter/Danaher, Bio-Rad, CellaVision, Horiba, Nihon Kohden, Sekisui Diagnostics, Siemens Healthineers, Sysmex, and other suppliers.
2. Flow Cytometers
a. Introduction
b. System Overview
3. Platelet Aggregometers
4. Sedimentation Rate Analyzers
D. Market Needs and Future Demand for Hematology and Flow Cytometry Analyzers
E. Reagents and Controls
F. Current and Emerging Technologies
1. Information Technologies
2. Automation and Robotics
3. Lasers
4. Artificial Intelligence
5. Monoclonal Antibodies
6. Molecular Diagnostics
7. Microdrop Technology
VIII. FRANCE HEMATOLOGY AND FLOW CYTOMETRY MARKETS
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Test Volume and Sales Forecasts by Market Segment, Major Supplier Instrument Placements, Installed Base, Sales and Market Shares I
IX. GERMANY HEMATOLOGY AND FLOW CYTOMETRY MARKETS
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Test Volume and Sales Forecasts by Market Segment, Major Supplier Instrument Placements, Installed Base, Sales and Market Shares
X. ITALY HEMATOLOGY AND FLOW CYTOMETRY MARKETS
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Test Volume and Sales Forecasts by Market Segment, Major Supplier Instrument Placements, Installed Base, Sales and Market Shares
XI. SPAIN HEMATOLOGY AND FLOW CYTOMETRY MARKETS
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Test Volume and Sales Forecasts by Market Segment, Major Supplier Instrument Placements, Installed Base, Sales and Market Shares
XII. U.K. HEMATOLOGY AND FLOW CYTOMETRY MARKETS
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Test Volume and Sales Forecasts by Market Segment, Major Supplier Instrument Placements, Installed Base, Sales and Market Shares
XIII. COMPETITIVE ASSESSMENTS
The report provides strategic assessments of over 15 leading hematology and flow cytometry market players and start-up companies with innovative technologies and products, including:
Abbott
Agilent Technologies
Beckman Coulter/Danaher
Becton Dickinson
Bio-Rad
CellaVision
Horiba
Nihon Kohden
Ortho-Clinical Diagnostics
Roche
Sekisui Diagnostics
Siemens Healthineers
Sysmex and others
II. WORLDWIDE MARKET OVERVIEW
III. MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES
A. Instrumentation
B. Reagent Kits and Test Systems/Panels
C. Information Technology
D. Auxiliary Products
IV. DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS
V. ALTERNATIVE MARKET PENETRATION STRATEGIES
VI. POTENTIAL MARKET ENTRY BARRIERS AND RISKS
VII. WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW
A. Major Routine and Special Hematology Tests
1. Introduction
2. CBC Analysis
a. Hemoglobin Concentration
b. Hematocrit Determination
c. Red Blood Cell Count
d. Red Cell Indices
MCV
RDW
MCHC
CHCM
HDW
MCH
e. Red Cell Size Histograms
f. Platelets
Platelet Count
Platelet Size/MPV
PDW
Automated Systems
g. Reticulocytes
3. White Blood Cell Analysis
a. WBC Count
b. Five-Partial Differential Major Suppliers
c. Pattern Recognition Systems
d. Comparison of Major Differential Analyzers
4. Reticulocytes
5. Platelet Function Tests
6. Erythrocyte Sedimentation Rate/CRP
7. Red Cell Analysis
8. 2, 3 DPG
9. Red Cell Deformability
10. Neutrophil Function Tests
11. Semen Analysis
12. Bone Marrow Analysis
13. Urinalysis
B. Major Flow Cytometry Applications
1. Cell Surface Markers
a. Lymphocyte Subclassification CD4/CD8/CD34
Instrumentation and Reagent Test Kits
b. Other Cell Markers
2. DNA Content Analysis
3. RNA Content Analysis
4. Chemotherapy Monitoring
5. Cell Cycle Analysis
6. Chromosome Analysis
7. Fetal Cell Analysis
8. HLA Typing
9. Microbiology
10. Protein Content Analysis
11. Multiparameter Analysis
12. Other Applications
C. Hematology and Flow Cytometry Instrumentation Review
1. Hematology Analyzers
a. Overview
Electrical Aperture-Impedance Analyzers
Light Scatter Analyzers
b. Review of major analyzers from:
Abbott, Beckman Coulter/Danaher, Bio-Rad, CellaVision, Horiba, Nihon Kohden, Sekisui Diagnostics, Siemens Healthineers, Sysmex, and other suppliers.
2. Flow Cytometers
a. Introduction
b. System Overview
3. Platelet Aggregometers
4. Sedimentation Rate Analyzers
D. Market Needs and Future Demand for Hematology and Flow Cytometry Analyzers
E. Reagents and Controls
F. Current and Emerging Technologies
1. Information Technologies
2. Automation and Robotics
3. Lasers
4. Artificial Intelligence
5. Monoclonal Antibodies
6. Molecular Diagnostics
7. Microdrop Technology
VIII. FRANCE HEMATOLOGY AND FLOW CYTOMETRY MARKETS
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Test Volume and Sales Forecasts by Market Segment, Major Supplier Instrument Placements, Installed Base, Sales and Market Shares I
IX. GERMANY HEMATOLOGY AND FLOW CYTOMETRY MARKETS
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Test Volume and Sales Forecasts by Market Segment, Major Supplier Instrument Placements, Installed Base, Sales and Market Shares
X. ITALY HEMATOLOGY AND FLOW CYTOMETRY MARKETS
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Test Volume and Sales Forecasts by Market Segment, Major Supplier Instrument Placements, Installed Base, Sales and Market Shares
XI. SPAIN HEMATOLOGY AND FLOW CYTOMETRY MARKETS
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Test Volume and Sales Forecasts by Market Segment, Major Supplier Instrument Placements, Installed Base, Sales and Market Shares
XII. U.K. HEMATOLOGY AND FLOW CYTOMETRY MARKETS
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Test Volume and Sales Forecasts by Market Segment, Major Supplier Instrument Placements, Installed Base, Sales and Market Shares
XIII. COMPETITIVE ASSESSMENTS
The report provides strategic assessments of over 15 leading hematology and flow cytometry market players and start-up companies with innovative technologies and products, including:
Abbott
Agilent Technologies
Beckman Coulter/Danaher
Becton Dickinson
Bio-Rad
CellaVision
Horiba
Nihon Kohden
Ortho-Clinical Diagnostics
Roche
Sekisui Diagnostics
Siemens Healthineers
Sysmex and others
